← Back to Trial

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Trial Locations

• University of California, San Diego (UCSD) San Diego, California, United States
  • Contact: Rana McKay, MD · [email protected] (opens in new tab)
• Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Contact: Samuel R. Denmeade · 410-955-8875 · [email protected] (opens in new tab)
• Dana-Faber Cancer Institute Boston, Massachusetts, United States
  • Contact: Jacob Berchuck, MD · 919-452-4199 · [email protected] (opens in new tab)
• University of Minnesota Minneapolis, Minnesota, United States
  • Contact: Emmanuel Antonarakis, MD · [email protected] (opens in new tab)
• University of Nebraska Medical Center Omaha, Nebraska, United States
  • Contact: Benjamin Teply, MD · [email protected] (opens in new tab)
• University of Washington/Fred Hutchinson Cancer Center Seattle, Washington, United States
  • Contact: Michael Schweizer, MD · [email protected] (opens in new tab)